The Power List is our chance to put the pharmaceutical and drug development industry’s inspirational thought leaders, opinion shapers and unsung heroes in the spotlight. We’re relying on you to ensure that the breadth of perspectives is as wide as possible!
personalized, responsive service and to improve the site, we remember and store information about how you use
The Medicine Maker
“Welcome to the November issue. Upfront investigates the transparency of European clinical trials, gene-editing to protect mice from cocaine overdose and addiction, and how the FDA thinks manufacturing can be modernized. Frank Cordes explains how integrating automation and informatics will be made possible by Industry 4.0 in “In My View,” while our cover feature explores the pharma industry’s role in biodefense. In Best Practice, Mario Philips, Vice President and General Manager at Pall Biotech, discusses the evolution of single-use technology; and in Business, academics from the Campbell School of Business in the US explain the empirical evidence linking technology and financial decisions for start-ups in the pharma industry. We also Sit Down With Vivek Sharma, CEO of Piramal Pharma Solutions.